Poxel SA (France) Executives
| POXEL Stock | EUR 0.23 0.01 4.17% |
Poxel SA employs about 55 people. The company is managed by 10 executives with a total tenure of roughly 7 years, averaging almost 0.0 years of service per executive, having 5.5 employees per reported executive. Discussion of Poxel SA's management performance can provide insight into the enterprise performance.
| Quentin Durand Insider Chief VP |
| Bolze PharmD Insider COO CoFounder |
Poxel |
Poxel SA Management Team Effectiveness
The company has return on total asset (ROA) of (0.3038) % which means that it has lost $0.3038 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.2337) %, meaning that it generated substantial loss on money invested by shareholders. Poxel SA's management efficiency ratios could be used to measure how well Poxel SA manages its routine affairs as well as how well it operates its assets and liabilities.Poxel SA Workforce Comparison
Poxel SA is considered to be number one stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 118,073. Poxel SA adds roughly 55.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Poxel SA Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Poxel SA Price Series Summation is a cross summation of Poxel SA price series and its benchmark/peer.
Poxel SA Notable Stakeholders
A Poxel SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Poxel SA often face trade-offs trying to please all of them. Poxel SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Poxel SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Anne Renevot | Ex CFO | Profile | |
| Quentin Durand | Chief VP | Profile | |
| Bolze PharmD | COO CoFounder | Profile | |
| Sylvie Bertrand | VP HR | Profile | |
| Pascale MD | CoFounder Affairs | Profile | |
| Noah MBA | Exec Operations | Profile | |
| Sophie HallakouBozec | CoFounder Communication | Profile | |
| Elizabeth MBA | Corp Relations | Profile | |
| MBA PharmD | CEO CoFounder | Profile | |
| David MD | Ex Officer | Profile |
About Poxel SA Management Performance
The success or failure of an entity such as Poxel SA often depends on how effective the management is. Poxel SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Poxel management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Poxel management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. The company was founded in 2009 and is headquartered in Lyon, France. Poxel SA operates under Pharmaceuticals And Biosciences classification in France and is traded on Paris Stock Exchange. It employs 33 people.
Poxel SA Workforce Analysis
Traditionally, organizations such as Poxel SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Poxel SA within its industry.Poxel SA Manpower Efficiency
Return on Poxel SA Manpower
| Revenue Per Employee | 243.6K | |
| Revenue Per Executive | 1.3M | |
| Net Loss Per Employee | 432.1K | |
| Net Loss Per Executive | 2.4M | |
| Working Capital Per Employee | 709.1K | |
| Working Capital Per Executive | 3.9M |
Additional Tools for Poxel Stock Analysis
When running Poxel SA's price analysis, check to measure Poxel SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Poxel SA is operating at the current time. Most of Poxel SA's value examination focuses on studying past and present price action to predict the probability of Poxel SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Poxel SA's price. Additionally, you may evaluate how the addition of Poxel SA to your portfolios can decrease your overall portfolio volatility.